November 30, 2023 Paris, FRANCE, Boston, MA, USA BioSerenity, a leader in EEG Technology announces the FDA Clearance of Neuronaute® Plus. A device opening up new possibilities for EEG Recordings. Neuronaute® Plus is a small portable medical device collecting data…
Paris, 13 November 2023 Jolt Capital, an independent private equity firm specializing in growth investment in European deeptech companies, is investing €24m in BioSerenity, a specialist in connected medical devices and innovative medical services in electrophysiology. Thanks to the relevance…
Paris, July 21, 2023 BioSerenity, designer of innovative medical solutions in electrophysiology, has just reached a significant milestone in patient monitoring and diagnosis! To date, one million patients have benefited from its medical technologies in the fields of Neurology and…